Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eva P Cuevas

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Biomedicines|February 25, 2022
TDP-43 Pathology and Prionic Behavior in Human Cellular Models of Alzheimer's Disease PatientsEva P Cuevas, Alberto Rodríguez-Fernández, Valle Palomo, et al.
Biology Open|January 14, 2014
LOXL2 catalytically inactive mutants mediate epithelial-to-mesenchymal transitionEva P Cuevas, Gema Moreno-Bueno, Giacomo Canesin, et al.
Scientific Reports|March 24, 2017
LOXL2 drives epithelial-mesenchymal transition via activation of IRE1-XBP1 signalling pathwayEva P Cuevas, Pilar Eraso, María J Mazón, et al.
Neurobiology of Disease|March 17, 2025
MicroRNA signature of lymphoblasts from amyotrophic lateral sclerosis patients as potential clinical biomarkersEva P Cuevas, Enrique Madruga, Ignacio Valenzuela-Martínez, et al.
Frontiers in Molecular Neuroscience|August 25, 2023
TTBK1 and CK1 inhibitors restore TDP-43 pathology and avoid disease propagation in lymphoblast from Alzheimer's disease patientsLoreto Martinez-Gonzalez, Eva P Cuevas, Carlota Tosat-Bitrián, et al.
Journal of Hepatology|April 6, 2007
Role of insulin receptor substrate-4 in IGF-I-stimulated HEPG2 proliferationEva P Cuevas, Oscar Escribano, Antonio Chiloeches, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|April 25, 2024
Designing multitarget ligands for neurodegenerative diseases with improved permeability trough PLGA nanoencapsulationVanesa Nozal, Paula Fernández-Gómez, Alfonso García-Rubia, et al.
Plos One|April 5, 2013
E47 and Id1 interplay in epithelial-mesenchymal transitionEva Cubillo, Antonio Diaz-Lopez, Eva P Cuevas, et al.
International Journal of Cancer|September 3, 2014
Zeb1 and Snail1 engage miR-200f transcriptional and epigenetic regulation during EMTAntonio Díaz-López, Juan Díaz-Martín, Gema Moreno-Bueno, et al.
Journal of Neurochemistry|July 7, 2020
Therapeutic potential of novel Cell Division Cycle Kinase 7 inhibitors on TDP-43-related pathogenesis such as Frontotemporal Lobar Degeneration (FTLD) and amyotrophic lateral sclerosis (ALS)Gabriela Vaca, Loreto Martinez-Gonzalez, Ana Fernandez, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Biomedicines|February 25, 2022
TDP-43 Pathology and Prionic Behavior in Human Cellular Models of Alzheimer's Disease PatientsEva P Cuevas, Alberto Rodríguez-Fernández, Valle Palomo, et al.
Biology Open|January 14, 2014
LOXL2 catalytically inactive mutants mediate epithelial-to-mesenchymal transitionEva P Cuevas, Gema Moreno-Bueno, Giacomo Canesin, et al.
Scientific Reports|March 24, 2017
LOXL2 drives epithelial-mesenchymal transition via activation of IRE1-XBP1 signalling pathwayEva P Cuevas, Pilar Eraso, María J Mazón, et al.
Neurobiology of Disease|March 17, 2025
MicroRNA signature of lymphoblasts from amyotrophic lateral sclerosis patients as potential clinical biomarkersEva P Cuevas, Enrique Madruga, Ignacio Valenzuela-Martínez, et al.
Frontiers in Molecular Neuroscience|August 25, 2023
TTBK1 and CK1 inhibitors restore TDP-43 pathology and avoid disease propagation in lymphoblast from Alzheimer's disease patientsLoreto Martinez-Gonzalez, Eva P Cuevas, Carlota Tosat-Bitrián, et al.
Journal of Hepatology|April 6, 2007
Role of insulin receptor substrate-4 in IGF-I-stimulated HEPG2 proliferationEva P Cuevas, Oscar Escribano, Antonio Chiloeches, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|April 25, 2024
Designing multitarget ligands for neurodegenerative diseases with improved permeability trough PLGA nanoencapsulationVanesa Nozal, Paula Fernández-Gómez, Alfonso García-Rubia, et al.
Plos One|April 5, 2013
E47 and Id1 interplay in epithelial-mesenchymal transitionEva Cubillo, Antonio Diaz-Lopez, Eva P Cuevas, et al.
International Journal of Cancer|September 3, 2014
Zeb1 and Snail1 engage miR-200f transcriptional and epigenetic regulation during EMTAntonio Díaz-López, Juan Díaz-Martín, Gema Moreno-Bueno, et al.
Journal of Neurochemistry|July 7, 2020
Therapeutic potential of novel Cell Division Cycle Kinase 7 inhibitors on TDP-43-related pathogenesis such as Frontotemporal Lobar Degeneration (FTLD) and amyotrophic lateral sclerosis (ALS)Gabriela Vaca, Loreto Martinez-Gonzalez, Ana Fernandez, et al.
Pageof 2